Corporate | 11 May 2004 07:48

Eckert & Ziegler: 17% Sales Increase in First Quarter

Corporate-news announcement sent by DGAP. The sender is solely responsible for the contents of this announcement. ——————————————————————————– Eckert & Ziegler: 17% Sales Increase in First Quarter Berlin, 11 May 2004. Eckert & Ziegler AG (ISIN DE0005659700), a specialist in medical and industrial radiation technology, posted sales of 8.0 million EUR in the first quarter of 2004, an increase of 17% over the same quarter of last year. Of the 1.2 million EUR increase in sales, approximately 0.5 million EUR are based on newly acquired units but the rest is due to organic increases in the radiation therapy segment (oncology and cardiology). Revenue from ongoing business activities rose by 158% to 0.5 million EUR, and net income after taxes showed a profit of 0.4 million EUR, up from a loss of 0.5 million EUR for the same quarter of last year. For the current business year, the Executive Board anticipates sales of around 36 million EUR and a profit per share of approximately 0.40 EUR. Your contact for inquiries: Eckert & Ziegler AG, Karolin Riehle, Investor Relations Phone: +49 (0) 30 / 94 10 84-138 http://www.ezag.de end of message, (c)DGAP 11.05.2004 ——————————————————————————– WKN: 565970; ISIN: DE0005659700; Index: Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg, Hannover und Stuttgart 110748 Mai 04